Literature DB >> 27740858

Non-viral nucleic acid delivery methods.

Igor Slivac1, David Guay2, Mathias Mangion3, Juliette Champeil3, Bruno Gaillet3.   

Abstract

INTRODUCTION: Delivery of nucleic acid-based molecules in human cells is a highly studied approach for the treatment of several disorders including monogenic diseases and cancers. Non-viral vectors for DNA and RNA transfer, although in general less efficient than virus-based systems, are particularly well adapted mostly due to the absence of biosafety concerns. Non-viral methods could be classified in two main groups: physical and vector-assisted delivery systems. Both groups comprise several different methods, none of them universally applicable. The choice of the optimal method depends on the predefined objectives and the features of targeted micro-environment. Areas covered: In this review, the authors discuss non-viral techniques and present recent therapeutic achievements in ex vivo and in vivo nucleic acid delivery by most commonly used techniques while emphasizing the role of 'biological particles', namely peptide transduction domains, virus like particles, gesicles and exosomes. Expert opinion: The number of available non-viral transfection techniques used for human therapy increased rapidly, followed by still moderate success in efficacy. The prospects are to be found in design of multifunctional hybrid systems that reflect the viral efficiency. In this respect, biological particles are very promising.

Entities:  

Keywords:  Nucleic acid delivery; exosomes; particle mediated transfection; peptide transduction domains; physical transfection; virus derived particles

Mesh:

Substances:

Year:  2016        PMID: 27740858     DOI: 10.1080/14712598.2017.1248941

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  18 in total

Review 1.  Progress of cationic gene delivery reagents for non-viral vector.

Authors:  Kai Ma; Chun-Liu Mi; Xiang-Xiang Cao; Tian-Yun Wang
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-04       Impact factor: 4.813

2.  Production and Use of Gesicles for Nucleic Acid Delivery.

Authors:  Mathias Mangion; Marc-André Robert; Igor Slivac; Rénald Gilbert; Bruno Gaillet
Journal:  Mol Biotechnol       Date:  2021-10-01       Impact factor: 2.695

3.  Orthopaedic Gene Therapy: Twenty-Five Years On.

Authors:  Christopher H Evans; Steve C Ghivizzani; Paul D Robbins
Journal:  JBJS Rev       Date:  2021-08-26

4.  Effects of spinal non-viral interleukin-10 gene therapy formulated with d-mannose in neuropathic interleukin-10 deficient mice: Behavioral characterization, mRNA and protein analysis in pain relevant tissues.

Authors:  Arden G Vanderwall; Shahani Noor; Melody S Sun; Jacob E Sanchez; Xuexian O Yang; Lauren L Jantzie; Nikolaos Mellios; Erin D Milligan
Journal:  Brain Behav Immun       Date:  2017-11-04       Impact factor: 7.217

Review 5.  The Potential of Zebrafish as a Model Organism for Improving the Translation of Genetic Anticancer Nanomedicines.

Authors:  C Gutiérrez-Lovera; A J Vázquez-Ríos; J Guerra-Varela; L Sánchez; M de la Fuente
Journal:  Genes (Basel)       Date:  2017-11-28       Impact factor: 4.096

6.  Application and Evaluation of [99mTc]-Labeled Peptide Nucleic Acid Targeting MicroRNA-155 in Breast Cancer Imaging.

Authors:  Yaqun Jiang; Yongkang Gai; Yu Long; Qingyao Liu; Chunbao Liu; Yongxue Zhang; Xiaoli Lan
Journal:  Mol Imaging       Date:  2020 Jan-Dec       Impact factor: 4.488

7.  RNA-guided piggyBac transposition in human cells.

Authors:  Brian E Hew; Ryuei Sato; Damiano Mauro; Ilko Stoytchev; Jesse B Owens
Journal:  Synth Biol (Oxf)       Date:  2019-07-02

8.  Suprachoroidal gene transfer with nonviral nanoparticles.

Authors:  Jikui Shen; Jayoung Kim; Stephany Y Tzeng; Kun Ding; Zibran Hafiz; Da Long; Jiangxia Wang; Jordan J Green; Peter A Campochiaro
Journal:  Sci Adv       Date:  2020-07-03       Impact factor: 14.136

9.  Dynamic profiles, biodistribution and integration evaluation after intramuscular/intravenous delivery of a novel therapeutic DNA vaccine encoding chicken type II collagen for rheumatoid arthritis in vaccinated normal rodent.

Authors:  Xiao Zhao; Juan Long; Fei Liang; Nan Liu; Yuying Sun; Yongzhi Xi
Journal:  J Nanobiotechnology       Date:  2019-09-06       Impact factor: 10.435

10.  Reduced hypertrophy in vitro after chondrogenic differentiation of adult human mesenchymal stem cells following adenoviral SOX9 gene delivery.

Authors:  M Weissenberger; M H Weissenberger; F Gilbert; J Groll; C H Evans; A F Steinert
Journal:  BMC Musculoskelet Disord       Date:  2020-02-17       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.